US Patent Issued to Yeda Research and Development on Jan. 13 for "DNA repair blood test for predicting response of lung cancer patients to immunotherapy" (Israeli Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,523,657, issued on Jan. 13, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel).

"DNA repair blood test for predicting response of lung cancer patients to immunotherapy" was invented by Zvi Livneh (Rehovot, Israel) and Tamar Paz-Elizur (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of selecting a treatment for a subject having cancer is disclosed. The method comprises: (a) determining a level of catalytic activity of at least one DNA repair enzyme in a biological sample of the subject; and (b) selecting an immune checkpoint regulator as a treatment for a subject having a statistically significant different ...